# Filing Detail

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001104659-24-129424
Filing Date
2024-12-17
Accepted
2024-12-17 17:09:39
Documents
62

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | F-1/A | tm2427973-5_f1a.htm | F-1/A | 2134845
2 | EXHIBIT 1.1 | tm2427973d6_ex1-1.htm | EX-1.1 | 80940
3 | EXHIBIT 4.7 | tm2427973d6_ex4-7.htm | EX-4.7 | 94991
4 | EXHIBIT 4.8 | tm2427973d6_ex4-8.htm | EX-4.8 | 98903
5 | EXHIBIT 5.1 | tm2427973d6_ex5-1.htm | EX-5.1 | 49722
6 | EXHIBIT 10.18 | tm2427973d6_ex10-18.htm | EX-10.18 | 206851
7 | EXHIBIT 23.1 | tm2427973d6_ex23-1.htm | EX-23.1 | 2837
8 | EX-FILING FEES | tm2427973d6_ex-filingfees.htm | EX-FILING FEES | 31190
9 | GRAPHIC | lg_evaxion-bwlr.jpg | GRAPHIC | 12591
10 | GRAPHIC | fc_immun-4c.jpg | GRAPHIC | 105452
11 | GRAPHIC | fc_strategy-4c.jpg | GRAPHIC | 132876
12 | GRAPHIC | tb_milestones-4c.jpg | GRAPHIC | 111477
13 | GRAPHIC | fc_aiimmunology-4c.jpg | GRAPHIC | 91703
14 | GRAPHIC | fc_cancer-4c.jpg | GRAPHIC | 60354
15 | GRAPHIC | fc_stageofdevelop-4c.jpg | GRAPHIC | 92932
16 | GRAPHIC | fc_cells-4c.jpg | GRAPHIC | 51252
17 | GRAPHIC | bc_bestranked-4c.jpg | GRAPHIC | 36851
18 | GRAPHIC | lc_cellinoculation-4c.jpg | GRAPHIC | 92243
19 | GRAPHIC | fc_pioneerrna-4c.jpg | GRAPHIC | 52253
20 | GRAPHIC | fc_cancervaccines-4c.jpg | GRAPHIC | 42428
21 | GRAPHIC | fc_vaccinetreat-4clr.jpg | GRAPHIC | 96229
22 | GRAPHIC | tb_diseasestage-4c.jpg | GRAPHIC | 110882
23 | GRAPHIC | bc_changetrg-4c.jpg | GRAPHIC | 51187
24 | GRAPHIC | lc_prepost-bw.jpg | GRAPHIC | 59818
25 | GRAPHIC | lc_prepostfollow-bw.jpg | GRAPHIC | 46903
26 | GRAPHIC | lc_pioneerscore-bw.jpg | GRAPHIC | 45148
27 | GRAPHIC | lc_shortlong-4c.jpg | GRAPHIC | 75791
28 | GRAPHIC | fc_screening-4c.jpg | GRAPHIC | 25983
29 | GRAPHIC | bc_sfupbmc-4c.jpg | GRAPHIC | 83884
30 | GRAPHIC | fc_cd4cd8cells-4c.jpg | GRAPHIC | 74826
31 | GRAPHIC | lc_neoagspearson-4c.jpg | GRAPHIC | 70888
32 | GRAPHIC | bc_patient-4c.jpg | GRAPHIC | 67682
33 | GRAPHIC | bc_preexisting-4c.jpg | GRAPHIC | 81117
34 | GRAPHIC | fc_evx02-4clr.jpg | GRAPHIC | 95190
35 | GRAPHIC | lc_empty-4c.jpg | GRAPHIC | 35955
36 | GRAPHIC | lc_tumar-4c.jpg | GRAPHIC | 59489
37 | GRAPHIC | lc_tumarvalume-4c.jpg | GRAPHIC | 78429
38 | GRAPHIC | lc_emptyplasmid-4c.jpg | GRAPHIC | 73045
39 | GRAPHIC | lc_tumorvolume-4c.jpg | GRAPHIC | 128548
40 | GRAPHIC | fc_vehiclecontrol-4c.jpg | GRAPHIC | 135671
41 | GRAPHIC | lc_clinical-4c.jpg | GRAPHIC | 106643
42 | GRAPHIC | lc_liuhugoanti-4c.jpg | GRAPHIC | 155237
43 | GRAPHIC | fc_datacuration-4c.jpg | GRAPHIC | 55331
44 | GRAPHIC | fc_discovery-4c.jpg | GRAPHIC | 160498
45 | GRAPHIC | lc_bacteria-4c.jpg | GRAPHIC | 154890
46 | GRAPHIC | fc_proteins-4c.jpg | GRAPHIC | 118887
47 | GRAPHIC | fc_evxb1-4c.jpg | GRAPHIC | 62087
48 | GRAPHIC | lc_postinfection-4c.jpg | GRAPHIC | 22562
49 | GRAPHIC | lc_abcessarea-4c.jpg | GRAPHIC | 37776
50 | GRAPHIC | lc_halfmaxtiter-4c.jpg | GRAPHIC | 21103
51 | GRAPHIC | lc_kidneys-4c.jpg | GRAPHIC | 24535
52 | GRAPHIC | fc_ngo265-4c.jpg | GRAPHIC | 174298
53 | GRAPHIC | lc_postinfections-4c.jpg | GRAPHIC | 277722
54 | GRAPHIC | lc_auccfu-4c.jpg | GRAPHIC | 62059
55 | GRAPHIC | lc_immunizations-4c.jpg | GRAPHIC | 25560
56 | GRAPHIC | bc_splenocytes-4c.jpg | GRAPHIC | 38054
57 | GRAPHIC | bc_killing-4c.jpg | GRAPHIC | 65238
58 | GRAPHIC | fc_identification-4c.jpg | GRAPHIC | 82717
59 | GRAPHIC | bc_sarsgenome-4c.jpg | GRAPHIC | 38363
60 | GRAPHIC | bc_antibody-4c.jpg | GRAPHIC | 20090
61 | GRAPHIC | tm2427973d4_ex5-1img001.jpg | GRAPHIC | 3052
62 | GRAPHIC | tm2427973d4_ex5-1img02.jpg | GRAPHIC | 763
| Complete submission text file | 0001104659-24-129424.txt |  | 8181094

Mailing Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970
Business Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970 004531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-283304 | Film No.: 241556626
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)